Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Appropriate payment, including risk adjustment, for D-SNPs and MMPs
Appropriate quality measurement for D-SNPs and MMPs
"Protect Maintenance of Effort (MOE) requirements in
Section 6008(b) of the Families First Coronavirus Response Act"
Education, implementation, evaluation, and improvement of coordinated care programs for dual eligibles
Legislative solution to address churning in Medicaid/CHIP eligibility in both programs
Medicaid and Medicare reform discussions with MACPAC and MedPAC
Medicaid eligibility and enrollment issues
Medicaid health plans serving as qualified health plans in the Exchange
Medicaid quality measurement and improvement
Medicaid expansion activities
Impact of Substance Use Disorder Treatment Privacy Protections on Medcare/Medicaid beneficiaries (42 CFR Part 2)
Stabilize Medicaid and CHIP Coverage Act (H.R.1879/S.873)
Regulatory and systematic impact of Medicaid continuous coverage
SNP sustainability and improvements to MMPs
RADV audits
Enact risk corridors for Medicare Advantage Dual Eligible Special Needs Plans (D-SNPS) [Section 30213 of the HEROES Act
Designate employees in home and community based work as essential workers for the purpose of premium pay [Section 17101 - 17104 of the House-passed HEROES Act]
"Support the Coronavirus State Fiscal Relief Fund and the Coronavirus
Local Fiscal Relief Fund in Title III of the HEROES Act"
Medicare Special Enrollment Period
Medicare Presumptive Eligibility Guidance
Increase the Federal Medical Assistance Percentage (FMAP)
Institute a Moratorium on the Medicaid Fiscal Accountability Regulation (MFAR) until after the PHE
"Expand the availability of the FCC Lifeline program during
the current COVID-19 public health emergency"
H.R. 6926, the Meeting IMD Needs with Direction (MIND) Act
H.R. 4996, the Helping Medicaid Offer Maternity Services (MOMS) Act
Actuarial soundness for Medicaid managed care payments
Impact of significant budget cuts in Medicaid
Medicaid managed care best practices
Medicaid managed care regulations
Medicaid Provider Payments
Network adequacy
Risk adjustment
Home and community based services
Capped Medicaid Funding Proposals
Impact of enhanced state flexibility in managing Medicaid programs
Including Medciaid Continuous Eligibility Maintenance of Effort requirements in H.R.6201, Families First Coronavirus Response Act
HR 6359 Coronavirus Medicaid Response Act
Ensure adeqate Medicaid Managed Care ratesetting through Coronavirus Emergency (H.R.748)
Institute moratorium on Medicaid Financial Accountability Rule through Coronavirus emergency (H.R.748)
Protecting Medicaid Non-Emergency Transportation benefits through coronavirus pandemic emegency (H.R.748)
Adequate ratesetting for Medicare Advantage and MMPs to account for increased COVID-19 costs (H.R.748)
Suspend MA-PD audits, including RADV audits, through pendemic emergency period (H.R.748)
Include COVID-19 pandemic in "Extreme and Uncontrollable Circumstances" policy for CY2021 MA STARS ratings (H.R.748)
Permit MA D-SNPs and MMPs to substitute face-to-face care coordination activities with telephonic or telehealth management (H.R.748)
Regulatory relief for Managed Long Term Supports and Services Plans during COVID-19 pandemic (H.R.748)
Medicaid PCP rate increase
HR 6800, the HEROES Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), U.S. HOUSE OF REPRESENTATIVES, Substance Abuse & Mental Health Services Administration (SAMHSA), Medicare Payment Advisory Commission (MedPAC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Continuous eligibility and coordination between Medicaid and Marketplace to support continuous care
Risk adjustment
Availability of premium tax credits for enrollees in the Federally Facilitated Marketplace
HR 6800, the HEROES Act
H.R.1425, the Patient Protection and Affordable Care Enhancement Act (ACEA)
Addressing bureaucratic hurdles to treating substance use disorder in care coordinated systems created by 42 CFR Part 2
Short-term, limited-duration insurance
H.R.3630, No Suprises Act
S. 1895 Lower Health Care Costs Act
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
S. 1556, No Junk Plans Act
Lower Health Care Costs Act (S. 1895)
Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3)
HR 1010, reversing the Administration's rule on short-term, limited-duration insurance
Surprise Billing
Special Enrollment Period for Marketplace
Reinsurance
Affordable Care Act implementation with respect to safety net health plans
Network adequacy

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

H.R.6379, Take Responsibility for Workers and Families Act
H.Res.906 - Calling on the President to invoke the Defense Production Act to respond to COVID-19
H.R.6201, the Families First Coronavirus Response Act
H.R.6074, Coronavirus Supplemental Appropriations
Health provisions of budget proposals
" H.R. 748, the Coronavirus Aid, Relief, and Economic Security
(CARES) Act"
Including legislation to address 42 CFR Part 2 Reform in HR 1865
HR 6800, the HEROES Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes